Table 3.
Weight-based (n=283) |
Glucose-based (n=292) |
|
Demographic characteristics | ||
Sex (M, %) | 168 (59.4) | 168 (57.5) |
Age (years) | 58.9 (8.8) | 59.7 (9.2) |
Diabetes duration (years) | 6.3 (6.7) | 7.0 (7.5) |
Weight (kg) | 64.4 (11.4) | 65.5 (11.8) |
BMI (kg/m2) | 24.4 (3.9) | 24.7 (3.9) |
Clinical characteristics | ||
HbA1c (%) | 10.9 (2.4) | 11.1 (2.5) |
C-peptide (μg/L) | 2.2 (2.1) | 2.0 (1.1) |
Admission BG (mmol/L) | 17.9 (5.3) | 18.6 (5.4) |
Admission diagnosis (n, %) | ||
Uncontrolled hyperglycemia | 181 (64.0) | 179 (61.3) |
DK/DKA | 45 (15.9) | 52 (17.8) |
Pneumonia | 18 (6.4) | 7 (2.4) |
Urine tract infection | 24 (8.5) | 28 (9.6) |
Diabetic foot | 9 (3.2) | 17 (5.8) |
Other infections | 6 (2.1) | 9 (3.1) |
Previous diabetes treatment (n, %) | ||
None | 106 (37.5) | 108 (37.0) |
OHA or GLP-1RA | 95 (33.6) | 97 (33.2) |
One type | 25 (8.8) | 24 (8.2) |
Two types | 33 (11.7) | 31 (10.6) |
Three or over three types | 37 (13.1) | 42 (14.4) |
Insulin alone | 23 (8.1) | 28 (9.6) |
Both OHA and insulin | 38 (13.4) | 37 (12.7) |
Values are n (%) or mean (SD) unless otherwise stated. Other infection includes upper respiratory infection, skin ulcer and shingles.
BG, blood glucose; BMI, body mass index; DK, diabetic ketosis; DKA, diabetic ketoacidosis; GLP-1RA, glucagon-like peptide-1 receptor agonist; HbA1c, hemoglobin A1c; OHA, oral hypoglycemic agent.